High Throughput Screening in Drug Discovery: Problems and Solutions

Hushpulian, D.M.; Gaisina, I.N.; Nikulin, S.V.; Chubar, T.A.; Savin, S.S.; Gazaryan, I.G.; Tishkov, V.I.

Авторы: Hushpulian D.M., Gaisina I.N., Nikulin S.V., Chubar T.A., Savin S.S., Gazaryan I.G., Tishkov V.I.
Журнал: Moscow University Chemistry Bulletin
Том: 79
Номер: 2
Год издания: 2024
Издательство: Allerton Press Inc.
Местоположение издательства: United States
Первая страница: 93
Последняя страница: 104
DOI: 10.3103/s0027131424700081
Аннотация: World-wide introduction of high throughput screening (HTS) methods in drug discovery research did not result in the increased number of novel medications on the market. We discuss novel trends in drug discovery that came from the understanding that majority of diseases are multifactorial and that one enzyme has many protein substrates. Hence, new approaches are focused on development of drugs, which (1) trigger survival pathways to return the organism to homeostatic balance, and (2) inhibit enzymes modifying histones or transcription factors not at the active site, but by displacement of protein substrates from the enzyme complexes. A good example for both approaches comes from the development of activators of antioxidant defense. We analyze and illustrate problems of commonly used in vitro HTS assays, and briefly discuss advantages and limitations of small animal models. The novel approaches are complementary to the standard HTS and do not substitute for testing in mammals. Development of transgenic reporter mice to monitor drug effects by means of in vivo imaging is extremely promising to select proper dosage and administration regimes for full-range PK studies.
Добавил в систему: Тишков Владимир Иванович

	ИСТИНА	Войти в систему Регистрация
	ИСТИНА ИНХС РАН
	Главная Поиск Статистика О проекте Помощь

ИСТИНА

ИСТИНА ИНХС РАН

High Throughput Screening in Drug Discovery: Problems and Solutionsстатья

Прикрепленные файлы